D18.02
Hemangioma of intracranial structures
Clinical Classification Guidelines
Medical Intelligence & Overview
Hemangioma of intracranial structures is a benign (non-cancerous) growth composed of newly formed blood vessels located within the brain. This condition is a type of vascular anomaly that can occur in various parts of the brain, including the cerebrum, cerebellum, or brainstem. Although usually benign, its presence can sometimes lead to neurological symptoms or complications depending on its size and location. Understanding the nature of this condition is essential for recognizing potential health implications and the importance of appropriate medical evaluation.
Causes & Symptoms
Clinical Causes: Sometimes, hemangiomas are congenital, meaning they are present at birth and result from abnormalities in blood vessel development during fetal growth. Certain genetic syndromes or familial conditions may predispose individuals to develop vascular anomalies like hemangiomas. In many cases, the exact cause of intracranial hemangiomas remains unknown, with no clear link to environmental or lifestyle factors.
Key Symptoms: Headaches that may vary in intensity and persistence Seizures or convulsions, especially if the hemangioma irritates or compresses nearby brain tissues Localized neurological deficits, such as weakness, numbness, or difficulty speaking, depending on the affected area Visual disturbances if the lesion impacts visual pathways Signs of increased intracranial pressure, such as nausea, vomiting, or altered consciousness, particularly in larger lesions
Diagnostic & Treatment
Diagnosis Path: Diagnosing intracranial hemangiomas typically involves a combination of medical history review and neurological examination. Imaging studies are crucial for accurate diagnosis, including: - Magnetic Resonance Imaging (MRI): Provides detailed images of brain structures and helps characterize the nature and extent of the hemangioma. - Computed Tomography (CT) scan: Useful in detecting calcifications and assessing any bleeding or hemorrhage within the lesion. - Angiography: An invasive procedure that visualizes blood vessels and can help differentiate hemangiomas from other vascular malformations or tumors. Additional tests may be conducted to determine the bleeding risk or plan potential treatment options.
Treatment Protocols: Management of intracranial hemangiomas depends on factors like size, location, the presence of symptoms, and potential for complications. Treatment options may include: - Observation: Small, asymptomatic hemangiomas may simply be monitored over time with regular imaging studies. - Medications: Certain drugs can help control symptoms like seizures. - Surgical removal: Indicated when the lesion causes significant neurological deficits, bleeding, or increased pressure. - Radiotherapy or stereotactic radiosurgery: Targeted treatments that can reduce the size of the hemangioma or prevent growth in specific cases. - Endovascular procedures: Minimally invasive techniques to embolize or block blood supply to the lesion. A multidisciplinary team involving neurologists, neurosurgeons, and radiologists typically collaborates to determine the most appropriate management plan.
Clinical Advice & FAQs
Billing Guidance
Is D18.02 a billable ICD-10 code?
Yes, D18.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D18.02?
Clinical documentation must specify the nature of Hemangioma of intracranial structures and any associated comorbidities for accurate reporting.
Cite this Clinical Reference